解读中国首部《中国老年人甲状腺疾病诊疗专家共识》

Interpretation of China’s first "Expert Consensus on Diagnosis and Treatment for Elderly with Thyroid Diseases in China"

摘要:

2021年5月《中华老年医学杂志》和《中华内分泌代谢杂志》同步发表了《中国老年人甲状腺疾病诊疗专家共识》（简称《共识》），这是由内分泌代谢病和老年病专科医生共同制定的我国首部针对老年人甲状腺疾病诊疗的共识。《共识》包括5个部分，共提出40条推荐意见。结合中国的流行病学数据，以及国内外相关文献和证据，该指南着重关注老年甲状腺疾病患者的综合评估与筛查；老年人甲亢的临床特点、并发症及治疗的注意事项；老年人甲减、亚临床甲减并发症及个体化治疗选择和目标；老年人分化型甲状腺癌的临床特点及分层管理。该共识对提高我国老年人甲状腺疾病的临床诊疗水平、促进健康老龄化具有重要意义。

Abstract:

In May 2021, the "Expert Consensus on Diagnosis and Treatment for Elderly with Thyroid Diseases in China" (herinafter as the "Consensus" ) was published on the Chinese Journal of Geriatrics and the Chinese Journal of Endocrinology and Metabolism, simultaneously. This is the first consensus on the diagnosis and treatment of thyroid diseases for the elderly in China, which is drafted by endocrinologists and geriatricians jointly. The Consensus consists of five parts, with a total of 40 recommendations. Based on the epidemiological data of China, as well as relevant literature and evidence from domestic and abroad studies, the Consensus focuses on comprehensive evaluation and screening of elderly patients with thyroid diseases; clinical characteristics and complications of senile hyperthyroidism and points for attention in treatment; complications of subclinical hypothyroidism in the elderly and individualized treatment options and goals; clinical characteristics and stratified management of differentiated thyroid carcinoma in the elderly. The Consensus is of great significance to improve the clinical diagnosis and treatment of senile thyroid diseases in China and to promote healthy aging.